Blog
RSS FeedPosted by Michael Wonder on 23 Oct 2020
TLV reconsiders the subsidy of Rinvoq
23 October 2020 - TLV starts a reconsideration of the current subsidy status for Rinvoq. ...
Posted by Michael Wonder on 23 Oct 2020
Efficiency ratio and rocketing drug prices: old concerns and new possibilities
23 October 2020 - One of the most significant phenomena in the recent years concerning the pharmaceutical industry and, at ...
Posted by Michael Wonder on 23 Oct 2020
Decision to widen access to a brand of long-acting methylphenidate
23 October 2020 - PHARMAC is pleased to announce widening of access to one brand of extended-release methylphenidate, Methylphenidate ER ...
Posted by Michael Wonder on 22 Oct 2020
FDA approves first treatment for COVID-19
22 October 2020 - Today, the U.S. Food and Drug Administration approved the antiviral drug Veklury (remdesivir) for use in adult ...
Posted by Michael Wonder on 22 Oct 2020
Nexplanon recommended after second submission
22 October 2020 - The first submission was withdrawn. ...
Posted by Michael Wonder on 22 Oct 2020
Will HIRA resume talk to grant benefits for anti-diabetic combo drugs?
22 October 2020 - Three makers of SGLT-2 inhibiting anti-diabetic drugs said they would seek changes in approval conditions to ...
Posted by Michael Wonder on 22 Oct 2020
CADTH in favour of new indication for Soliris
22 October 2020 - CADTH has finalised its assessment of eculizumab for adult patients with refractory generalised myasthenia gravis. ...
Posted by Michael Wonder on 22 Oct 2020
Trump promised seniors drug discount cards. They may be illegal.
22 October 2020 - A proposal announced by President Trump last month was to send older Americans $200 discount cards to ...
Posted by Michael Wonder on 22 Oct 2020
Remdesivir’s hefty price tag ignores NIH investment in its creation
22 October 2020 - Throughout the Democratic presidential primary, candidates cast a spotlight on the broken U.S. health care system ...
Posted by Michael Wonder on 22 Oct 2020
Budget is why PHARMAC is letting down New Zealanders, CEO says
22 October 2020 - PHARMAC is struggling to cater to the demand of Kiwis. ...
Posted by Michael Wonder on 22 Oct 2020
PHARMAC decision pending on life-changing diabetes medications
22 October 2020 - Government drug-funding agency PHARMAC is expected to decide next week whether it will fund two new ...
Posted by Michael Wonder on 22 Oct 2020
Leo Pharma announces U.S. FDA approval for Enstilar (calcipotriene and betamethasone dipropionate) foam U.S. Prescribing Information update to include data in long-term use in plaque psoriasis treatment
22 October 2020 - U.S. Prescribing Information updated to include PSO-LONG clinical trial data concerning long-term use (52 weeks) of twice-weekly ...
Posted by Michael Wonder on 22 Oct 2020
F2G receives second US FDA breakthrough therapy designation for Olorofim
22 October 2020 - In Phase 2b development for the treatment of life-threatening fungal infections. ...
Posted by Michael Wonder on 22 Oct 2020
Patients, health organisations band together to bring breakthrough treatments to Canada sooner
21 October 2020 - Thirteen health charities and patient groups are calling on the Canadian government to improve access to ...
Posted by Michael Wonder on 22 Oct 2020
$10,000 on new drugs every four months keeps melanoma patient alive
21 October 2020 - Graham Venning was given “weeks perhaps months” to live at the start of the year but ...